10.1016/j.neuint.2018.04.002 257 LiS.LiL.MinS.LiuS.QinZ.XiongZ.et al (2023c)
Finally, semaglutide has been linked to the development of thyroid tumors in rats
Proapoptotic activity of new glutathione S-transferase inhibitors
Where semaglutide falls short High-dose tirzepatide (10 to 15 mg) produces weight loss and metabolic effects that exceed what semaglutide can deliver at any approved dose
It is a flavonoid derived from the leaves of Myrica rubra, comprising protein, polyphenols, arabinose, and myricetinin as its chemical constituents
For a broader view of candidates advancing through late-stage development, our GLP-1 drug pipeline 2026 tracker covers the full field of emerging oral and injectable agents, including AstraZeneca and Eccogenes elecoglipron, for which Phase 3 trials were announced in January 2026, and Structure Therapeutics aleniglipron, which is advancing through Phase 2 with a Phase 3 programme expected to begin in the second half of 2026